CTOs on the Move

HMA Inc

www.hma-inc.com

 
HMA Inc is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.hma-inc.com
  • 1600 W Broadway Rd Ste 300
    Tempe, AZ USA 85282
  • Phone: 480.921.8944

Executives

Name Title Contact Details

Similar Companies

Circle Cardiovascular Imaging

Circle Cardiovascular Imaging is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Heritage Living Ctr

Heritage Living Ctr is a Ashland, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lourdes Hospital

Lourdes has as many faces as there are people in the community it serves. With its spiritual Catholic faith, Lourdes Hospital has provided compassionate care to those in need since 1925. In Binghamton, NY, our health system includes an Ambulatory Surgery Center, Home Care and Hospice services, and a Regional Cancer Center. Reaching beyond these boundaries, Lourdes has established a network of primary care physicians at convenient sites throughout the region. Our Mission In Motion program, provides women`s health services with a mobile medical van, making health care accessible to rural populations.

The American Academy of Anesthesiologist Assistants

The American Academy of Anesthesiologist Assistants is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alector

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.